List of works by Graham P Collins

A 72-year-old woman with a persistent cough and abnormal chest X-ray.

scientific article published in November 2014

A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma

scientific article

A phase I study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer

scientific article published on 17 October 2018

A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphoma.

scientific article

A rare but potentially fatal cause of diarrhoea and weight loss: enteropathy-associated T-cell lymphoma

scientific article published on 7 January 2015

Acute EBV masquerading as peripheral T-cell lymphoma.

scientific article published on 2 February 2016

Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.

scientific article published on 21 May 2014

CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.

scientific article

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma

scientific article published on 01 November 2018

CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.

scientific article

Classical Hodgkin's lymphoma: past, present and future perspectives

scientific article

Cumulative burden of disease: a relevant measure of the late side-effects of cancer treatment

scientific article published on 25 July 2016

Current treatment and future prospects for peripheral T-cell lymphoma.

scientific article published on October 2013

Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.

scientific article

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

scientific article published on 06 September 2018

Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies

scientific article published in August 2004

Focal segmental glomerulosclerosis in a patient with mantle cell lymphoma

scientific article published on 9 September 2015

Gemcitabine-induced large vessel vasculitis demonstrated by PET CT: a rare, important side effect.

scientific article published on 2 March 2014

Granulocyte and erythropoietic stimulating proteins after high-dose chemotherapy for myeloma.

scientific article published on 10 September 2007

Guideline on the management of primary resistant and relapsed classical Hodgkin lymphoma

scientific article published on 01 October 2013

Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens

scientific article

Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease.

scientific article

Immune checkpoint inhibition in lymphoid disease.

scientific article published on 30 March 2015

Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety

scientific article published on 01 June 2018

Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies

scientific article published on 22 November 2018

Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experience.

scientific article published on 4 May 2015

Long-term outcomes of autologous stem cell transplantation for peripheral T-cell lymphomas across the Thames Valley (1997-2012)

scientific article published on 16 November 2014

MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.

scientific article published on 29 June 2007

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma

scientific article published on 2 February 2018

Management and controversies of classical Hodgkin lymphoma in pregnancy

scientific article

Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries

scientific article published on 16 January 2018

NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome

scientific article published on 5 July 2016

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial

article

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

scientific article

Partial engraftment following plerixafor rescue after failed sibling donor peripheral blood stem cell harvest

scientific article published on 30 September 2013

Pharmacotherapy of anemia in cancer patients

scientific article published on 01 March 2008

Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre.

scientific article published on 19 September 2009

RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial

scientific article published on 9 November 2018

Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response-adapted design in the first-line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comor

scientific article published on 14 September 2020

Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphoma

scientific article published on 29 July 2015

Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma

scientific article published on 24 March 2017

Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting

scientific article published on 31 August 2017

Results of a multicentre UK-wide retrospective study evaluating the efficacy of pixantrone in relapsed, refractory diffuse large B cell lymphoma

scientific article published on 9 March 2016

Richter's syndrome of the brain and the spinal cord

scientific article

Seronegative antibody-mediated neurology after immune checkpoint inhibitors.

scientific article

Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients.

scientific article published on 24 October 2017

Subcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: a time and motion study in the United Kingdom.

scientific article published on 07 May 2014

T-cell/histiocyte-rich large B-cell lymphoma--transformation of nodular lymphocyte predominant Hodgkin lymphoma in the bone marrow.

scientific article published on 21 February 2014

Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma

scientific article

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients

scientific article published on 25 November 2018

Time now to TORC the TORC? New developments in mTOR pathway inhibition in lymphoid malignancies.

scientific article published on 19 May 2014

Toward a Biology-Driven Treatment Strategy for Peripheral T-cell Lymphoma

scientific article

Paulina is supported by:

About Paulina

Help